3247 |
PCI - Year in Review |
Neal S. Kleiman |
Apr. 20. 15 |
3246 |
Limited Adoption in Selected Patients Is Possible. |
Alaide Chieffo |
Apr. 20. 15 |
3245 |
Unrestricted Adoption in Real World Patients Is Possible. |
Patrick W. Serruys |
Apr. 20. 15 |
3244 |
The Sapien 3 Valve: Next Generation Balloon Expandable Valve Designed to Minimize Paravalvular Regurgitation |
Susheel Kodali |
Apr. 20. 15 |
3243 |
Corevalve Evolute R: The New Very Promising Generation of Corevalve |
Bernard R. Chevalier |
Apr. 20. 15 |
3242 |
FORTIS Transcatheter Mitral Valve for Treatment of a Patient with Severe Mitral Regurgitation |
Jian (James) Ye |
Apr. 20. 15 |
3241 |
Experience in Complex Lesions & Acute MI |
Corrado Tamburino |
Apr. 20. 15 |
3240 |
Clinical Data: What Do We Learn from Absorb II Trial? |
Bernard R. Chevalier |
Apr. 20. 15 |
3239 |
The Lotus Valve: Minimization of Paravalvular Leak with a Repositionable Next Generation TAVR Device |
Ted Feldman |
Apr. 20. 15 |
3238 |
Syntax 2 case : Multivessel Coronary Disease but Single Wessel Intervention |
Pawel E. Buszman |
Apr. 20. 15 |